[1]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1-8.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(05):1-8.[doi:10.12174/j.issn.2096-9600.2022.05.01]
点击复制

基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年05期
页码:
1-8
栏目:
出版日期:
2022-05-15

文章信息/Info

Title:
The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2
作者:
张维芯, 周青, 戴国梁, 邹建东, 寇建秋
江苏省中医院，江苏 南京 210029
Author(s):
ZHANG Weixin, ZHOU Qing, DAI Guoliang, ZOU Jiandong, KOU Jianqiu
Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China
关键词:
新型冠状病毒; 网络药理学; 血管紧张素转换酶2; 葛根; 柴胡
Keywords:
COVID-19; network pharmacology; ACE2
分类号:
R373
DOI:
10.12174/j.issn.2096-9600.2022.05.01
文献标志码:
A
摘要:
目的基于新型冠状病毒（Severe Acute Respiratory Syndrome Coronavirus 2，SARS-CoV-2）靶蛋白血管紧张素转化酶2（Angiotensin-converting enzyme 2，ACE2）探索“葛根-柴胡”治疗新型冠状病毒肺炎（Corona Virus Disease 2019，COVID-19）的潜在机制及可能性。 方法参考青岛海洋科学与技术试点国家实验室提供的COVID-19药物靶标蛋白，借助中药系统药理学分析平台（TCMSP）筛选“葛根-柴胡”活性成分及靶标蛋白；通过富集分析预测其作用机制；将“葛根-柴胡”主要活性成分与Spike-RBD、ACE2和Mpro进行分子对接验证；通过《中医方剂大辞典》筛选“葛根-柴胡”主治症候群。 结果“葛根-柴胡”活性成分与ACE2直接/间接作用蛋白的交集靶点共3个；葛根素与Spike-RBD、ACE2有较好的结合能力；《中医方剂大辞典》收录“葛根-柴胡”治疗外感、温病、瘟疫、疫病方剂共110首，其主治症候频次以恶寒、无汗、头痛、身热最高。 结论“葛根-柴胡”具有治疗COVID-19的潜在可能性，其相关机制可能涉及其活性成分葛根素与Spike-RBD、ACE2、Mpro对接，间接干扰SARS-CoV-2与ACE2蛋白结合。
Abstract:
ObjectiveTo explore the potential mechanism and the possibility of “Gegen-Chaihu” in the treatment of COVID-19 on the foundation of SARS-CoV-2 target protein ACE2. MethodsBy consulting COVID-19 drug target proteins provided by pilot national laboratory for marine science and technology (Qingdao), the active ingredients and target protein of “Gegen-Chaihu” were screened via TCMSP, the mechanism was predicted by enrichment analysis, the main active ingredients of “Gegen-Chaihu” were verified by molecular docking with Spike-RBD, ACE2 and Mpro; the primary indications of “Gegen-Chaihu” were screened through the dictionary of TCM prescriptions. ResultsThere were three intersection targets of the active ingredients of “Gegen-Chaihu” and ACE2 direct/indirect action protein; puerarin had better binding ability to Spike-RBD and ACE2; the dictionary of TCM prescriptions included 110 prescriptions containing “Gegen-Chaihu” in the treatment of exogenous, febrile, pestilence and epidemic disease, and its indications of chills, no sweating, headache and general fever were in the highest frequency. Conclusion“Gegen-Chaihu” have the potential to treat COVID-19, and its relevant mechanism may involve the docking of puerarin with Spike-RBD, ACE2 and Mpro, indirectly interfering with the binding of SARS-CoV-2 to ACE2 protein.

相似文献/References:

[1]王 雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(S1):11.
　Under the Impact of COVID-9 Epidemic.Reflection on the Diagnosis and Treatment of Orthopedic Diseases[J].Western Journal of Traditional Chinese Medicine,2020,33(05):11.
[2]王雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(03):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]
　WANG Lei,LI Shenghua,ZHOU Mingwang.Reflection on the Diagnosis and Treatment of Orthopedic Diseases Under the Impact of COVID-19 Epidemic[J].Western Journal of Traditional Chinese Medicine,2020,33(05):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]
[3]苏莉,刘永民,刘永红,等.新型冠状病毒肺炎眼传播及其防控探讨[J].西部中医药,2020,33(S1):80.
　SU Li,LIU Yongmin,LIU Yonghong,et al.On Eye Transmission, the Prevention and Control of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(05):80.
[4]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[5]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[6]时佳,叶晨,杨宗国,等.非危重型新型冠状病毒肺炎97例临床观察[J].西部中医药,2022,35(03):5.[doi:10.12174/j.issn.2096-9600.2022.03.02]
　SHI Jia,YE Chen,YANG Zongguo,et al.Clinical Observation on 97 Patients with Non-critical Type COVID-19[J].Western Journal of Traditional Chinese Medicine,2022,35(05):5.[doi:10.12174/j.issn.2096-9600.2022.03.02]
[7]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[8]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[9]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(05):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[10]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]

备注/Memo

备注/Memo:
张维芯（1984—），男，硕士学位，高级工程师。研究方向：大数据分析及中医药信息数据挖掘。
更新日期/Last Update: 2022-06-24